Shingles Virus May Cause Heart Attacks and Strokes; The CBCD Explains
The varicella zoster virus (VZV), which causes shingles, is linked to a dangerous decrease in blood flow in the coronary arteries. (1)
Ever had chickenpox? The CBCD recommends Novirin or Gene-Eden-VIR against the latent varicella zoster virus, which can cause chickenpox and shingles.
The varicella zoster virus (VZV, also known as herpes zoster), is a herpes virus that normally causes chickenpox in childhood. The virus may re-activate to cause shingles in later life, and has been linked to a condition known as acute coronary syndrome (ACS). This condition causes a decrease “in blood flow in the coronary arteries such that part of the heart muscle is unable to function properly or dies.” (2) In one study that tested the association between VZV and ACS, “the risk of ACS was significantly higher in the herpes zoster group than in the control group.” (3)
Another study showed that the VZV may be responsible for another, similar condition. That study showed that the virus increases the risk of transient ischemic attacks (TIA), which are a dysfunction in the brain caused by a loss of blood flow, for stroke, and for myocardial infarctions (MI, also known as heart attacks) (3). “Risk factors for vascular disease were significantly increased in cases of HZ (herpes zoster) compared with controls… (and)…TIA and MI were increased in cases whose HZ occurred when they were younger than 40 years (3).”
According to study authors, the bottom line is that “…conditions that predispose to vascular disease…are significantly more common in subjects with HZ (3).”
“Shingles is caused by the varicella zoster virus, the same virus that causes chickenpox. After a person recovers from chickenpox, the virus stays in the body in a dormant (inactive) (latent) state. For reasons that are not fully known, the virus can reactivate years later, causing shingles.” (See the CDC’s website last updated on January 10, 2011) (4).
“A reactivation of VZV and an outbreak of Shingles can be bad enough without having to worry about the possibility of a heart attack or stroke. That’s why we recommend helping the immune system target the latent shingles virus.” – Greg Bennett, CBCD
Click to learn more about Gene-Eden-VIR and the latent VZV.
The formula of these natural antiviral products was tested by Hanan Polansky and Edan Itzkovitz from the CBCD in two clinical studies that followed FDA guidelines. The studies showed that the Gene-Eden-VIR and Novirin formula is effective against herpes viruses. The clinical studies were published in the peer reviewed, medical journal Pharmacology & Pharmacy, the first, in a special edition on Advances in Antiviral Drugs. Study authors wrote that, “individuals infected with (herpes viruses) … reported a safe decrease in their symptoms following treatment with Gene-Eden-VIR.” (5) The study authors also wrote that, “we observed a statistically significant decrease in the severity, duration, and frequency of symptoms.” (5)
Both products can be ordered online on the Novirin and Gene-Eden-VIR websites here:
http://www.novirin.com
and
http://www.gene-eden-vir.com
Novirin and Gene-Eden-VIR are natural antiviral dietary supplements. Their formula contains five natural ingredients: Selenium, Camellia Sinesis Extract, Quercetin, Cinnamomum Extract, and Licorice Extract. The first ingredient is a trace element, and the other four are plant extracts. Each ingredient and its dose was chosen through a scientific approach. Scientists at polyDNA, the company that invented and patented the formula, scanned thousands of scientific and medical papers published in various medical and scientific journals, and identified the safest and most effective natural ingredients against latent viruses. To date, Novirin and Gene-Eden-VIR are the only natural antiviral products on the market with published clinical studies that support their claims.
Note: Novirin has the same formula as Gene-Eden-VIR. However, it contains higher quality and more expensive ingredients.
All orders of Novirin and Gene-Eden-VIR are completely confidential, and no information is shared or sold to any third party. Privacy is assured.
References:
(1) Amsterdam EA, Wenger NK, Brindis RG, Casey DE Jr, Ganiats TG, Holmes DR Jr, Jaffe AS, Jneid H, Kelly RF, Kontos MC, Levine GN, Liebson PR, Mukherjee D, Peterson ED, Sabatine MS, Smalling RW, Zieman SJ; ACC/AHA Task Force Members. "2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines." Circulation. 2014 Dec 23;130(25):e344-426 http://www.ncbi.nlm.nih.gov/pubmed/25249585
(2) Wang CC1, Lin CL, Chang YJ, Wang GJ, Sung FC, Kao CH "Herpes zoster infection associated with acute coronary syndrome: a population-based retrospective cohort study." Br J Dermatol. 2014 May;170(5):1122-9. http://www.ncbi.nlm.nih.gov/pubmed/24354564
(3) Breuer J1, Pacou M, Gauthier A, Brown MM. "Herpes zoster as a risk factor for stroke and TIA: a retrospective cohort study in the UK." Neurology. 2014 Jan 21;82(3):206-12. http://www.ncbi.nlm.nih.gov/pubmed/24384645
(4) CDC – Shingles (Herpes Zoster). Last Updated January 10, 2011.
http://www.cdc.gov/shingles/about/overview.html
(5) Gene-Eden-VIR Is Antiviral: Results of a Post Marketing
Clinical Study. Published on August 12, 2013.
http://gene-eden-kill-virus.com/PP_Gene-Eden-VIR-is-Antiviral.pdf
Hanan Polansky
Lilac Corp.
5852509999
email us here
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

